LOS ANGELES — The Healthspan Collective announced today a strategic partnership with Regen Therapy, uniting two organizations committed to raising the standard for scientific rigor, clinical education, and clarity in the rapidly evolving longevity and regenerative medicine space.
“What makes this partnership compelling is that it’s not transactional. It’s a platform for shared intelligence, trusted education, and thoughtful deployment of next-generation therapies especially around cell signaling, regenerative aesthetics, and healthspan optimization,” says Sanjiv Lal, Co-Founder of Regen Therapy. “Rather than building in isolation, this creates a multiplier effect where insights, standards, and best practices move faster and reach clinicians who are actively implementing them.”
Together, the organizations aim to address one of the industry’s most persistent challenges:
separating credible, evidence-based approaches from the growing noise surrounding regenerative therapies.
The regenerative medicine market has experienced explosive growth in recent years, driven by rising chronic disease prevalence, technological breakthroughs, and strong investment momentum. According to industry data, the global regenerative medicine market was estimated at $43.8 billion in 2025 and is projected to grow from $53.7 billion in 2026 to approximately $212.8 billion by 2034.
Despite this growth, the field remains fragmented, with clinicians and health-adjacent professionals navigating a crowded marketplace often marked by inconsistent standards and uneven education. Together, Healthspan Collective and Regen Therapy aim to address this gap by providing curated access to credible science, responsible innovation, and practical
frameworks for real-world application.
Founded as both an education and distribution platform, Regen Therapy focuses on advancing regenerative signaling through its proprietary RegenQuantum™ cell factors technology. Unlike first- and second-generation regenerative approaches, such as stem cells or exosomes, RegenQuantum™ is acellular and DNA-free, designed to support the body’s innate repair
pathways without introducing living cells or genetic material. This distinction allows for greater consistency, scalability, and regulatory clarity across clinical settings.
“Most regenerative products in the market are inherently variable—different donors, culture conditions, passages, and handling can change what’s actually in the vial,” explains Arvind Chakravarthy, MD, MBA, Regen Therapy Co-founder and Partner.
“RegenQuantum™ is positioned as potency-assayed and quality-controlled so clinicians can build protocols that scale across locations and providers rather than ‘hope it behaves like the last batch.’” That emphasis on consistency, transparency, and cutting-edge technology is precisely what makes this partnership between Regen Therapy and the Healthspan Collective well-aligned.
The Healthspan Collective was created in response to the growing complexity and confusion within the longevity and regenerative health industry. After years of producing large-scale conferences, Founder and Chief Community Officer Elias Arjan identified the need for smaller, more intentional events where evidence-based companies and practitioners could engage in meaningful dialogue.
Members of the Healthspan Collective gain early access to emerging technologies, private educational sessions, and high-touch Healthspan Salons designed to foster direct connection with industry leaders, clinicians, and innovators at the forefront of the future of healthspan.
Through this partnership, Regen Therapy will participate in Healthspan Collective programming throughout 2026, including live events, educational webinars, and targeted initiatives. The partnership reflects a broader shift in the longevity sector toward smaller, more intentional platforms that prioritize trust, scientific integrity, and long-term impact over scale alone.
“We’re entering an era where the pace of innovation in regenerative medicine has outstripped our ability to evaluate it responsibly,” says Elias Arjan, Founder and Chief Community Officer of the Healthspan Collective. “The Healthspan Collective was created to slow the conversation down, curate it intelligently, and bring the right people into the same room. Regen Therapy stands out because of its commitment to transparency, consistency, and education—qualities that are essential if these technologies are going to scale ethically and meaningfully.”
About Healthspan Collective
The Healthspan Collective brings together clinicians, researchers, founders, and best-in-class brands through intimate live salons, flagship summits, ongoing digital programming, and a growing membership network. The platform was created in response to increasing fragmentation, hype, and inconsistency across the longevity and regenerative health sector.
Rather than operating as a traditional conference series or influencer-led media brand, the Healthspan Collective serves as a long-term partner platform—designed to support responsible innovation, clinical education, and scalable real-world implementation. Its mission is to elevate scientific rigor, foster meaningful collaboration, and create trusted pathways between
emerging technologies and the professionals tasked with deploying them.
For more information or partnership inquiries,
visit https://nas.io/healthspan-collective
and follow the Healthspan Collective on LinkedIn and Instagram.
About Regen Therapy
RegenTherapy® is a B2B scientifically and medically owned longevity and regenerative medicine platform delivering advanced cellular, peptide, and hormone-based solutions through a scalable, compliance-first ecosystem. By combining proprietary regenerative technologies, clinical strategy, education, and commercialization support, RegenTherapy enables partners to
launch and scale next-generation longevity programs with precision and impact.
For more
information, visit https://regentherapy.com/
Media Contact:
Klaudia Balogh
Head of Communications
Healthspan Collective
klaudia@healthspanevents.com
